{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:12:01Z","timestamp":1777867921397,"version":"3.51.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS116058"],"award-info":[{"award-number":["R01 NS116058"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG057290"],"award-info":[{"award-number":["R01 AG057290"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG053999"],"award-info":[{"award-number":["R01 AG053999"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL 149127"],"award-info":[{"award-number":["R01 HL 149127"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bpc.2024.107252","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:53:32Z","timestamp":1713786812000},"page":"107252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Neuroinflammation induced by amyloid-forming pancreatic amylin: Rationale for a mechanistic hypothesis"],"prefix":"10.1016","volume":"310","author":[{"given":"Noah S.","family":"Leibold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin","family":"Despa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2024.107252_bb0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0015","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneur.64.4.570","article-title":"Relation of diabetes to mild cognitive impairment","volume":"64","author":"Luchsinger","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bpc.2024.107252_bb0030","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1161\/STROKEAHA.121.034363","article-title":"Amylin dyshomeostasis hypothesis: small vessel-type ischemic stroke in the setting of type-2 diabetes","volume":"52","author":"Despa","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.bpc.2024.107252_bb0035","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bpc.2024.107252_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc08-1153","article-title":"Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial","volume":"32","author":"Cukierman-Yaffe","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2024.107252_bb0045","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","article-title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy","volume":"10","author":"Launer","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0050","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","article-title":"Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study","volume":"60","author":"Imfeld","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bpc.2024.107252_bb0055","article-title":"Diabetes mellitus and the risk of Alzheimer\u2019s disease: a nationwide population-based study","volume":"9","author":"Huang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bpc.2024.107252_bb0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bpc.2024.107252_bb0065","doi-asserted-by":"crossref","first-page":"2798269","DOI":"10.1155\/2016\/2798269","article-title":"Islet amyloid polypeptide: structure, function, and pathophysiology","volume":"2016","author":"Akter","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bpc.2024.107252_bb0070","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","article-title":"Beta-cell loss and beta-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition","volume":"178","author":"Jurgens","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bpc.2024.107252_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"H\u00f6ppener","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bpc.2024.107252_bb0080","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells","volume":"39","author":"Kahn","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2024.107252_bb0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.bpc.2024.107252_bb0090","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","article-title":"Control of energy homeostasis by amylin","volume":"69","author":"Lutz","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bpc.2024.107252_bb0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bpc.2024.107252_bb0100","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/en.2012-2138","article-title":"Circulating levels of IL-1B+IL-6 cause ER stress and dysfunction in islets from prediabetic male mice","volume":"154","author":"O\u2019Neill","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpc.2024.107252_bb0105","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.2337\/db13-0863","article-title":"Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1\u03b2 production and \u03b2-cell dysfunction","volume":"63","author":"Westwell-Roper","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2024.107252_bb0110","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00125-014-3304-y","article-title":"Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice","volume":"57","author":"Meier","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2024.107252_bb0115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00125-014-3447-x","article-title":"IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice","volume":"58","author":"Westwell-Roper","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2024.107252_bb0120","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1074\/jbc.M114.611111","article-title":"Short term exposure of beta cells to low concentrations of interleukin-1\u03b2 improves insulin secretion through focal adhesion and actin remodeling and regulation of gene expression","volume":"290","author":"Arous","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2024.107252_bb0125","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s00125-020-05232-2","article-title":"Low concentration IL-1\u03b2 promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro","volume":"63","author":"Templin","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2024.107252_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","article-title":"Inflammasome-independent regulation of IL-1-family cytokines","volume":"33","author":"Netea","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bpc.2024.107252_bb0135","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.3086977","article-title":"Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans","volume":"232","author":"Bendtzen","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.bpc.2024.107252_bb0140","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bpc.2024.107252_bb0145","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bpc.2024.107252_bb0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bpc.2024.107252_bb0155","doi-asserted-by":"crossref","first-page":"32145","DOI":"10.1073\/pnas.2009680117","article-title":"The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"117","author":"Lonnemann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.bpc.2024.107252_bb0160","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2146\/ajhp050341","article-title":"Pramlintide acetate","volume":"62","author":"McQueen","year":"2005","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.bpc.2024.107252_bb0165","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12977","article-title":"Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics","volume":"5","author":"Abedini","year":"2016","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.bpc.2024.107252_bb0170","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1172\/JCI85210","article-title":"RAGE binds preamyloid IAPP intermediates and mediates pancreatic \u03b2 cell proteotoxicity","volume":"128","author":"Abedini","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bpc.2024.107252_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2023.100083","article-title":"Fibril elongation by human islet amyloid polypeptide is the main event linking aggregation to membrane damage","volume":"3","author":"Elenbaas","year":"2023","journal-title":"BBA Adv."},{"issue":"16","key":"10.1016\/j.bpc.2024.107252_bb0180","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.0708354105","article-title":"Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane","volume":"105","author":"Engel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2024.107252_bb0185","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2337\/db07-0849","article-title":"Fas-associated death receptor signaling evoked by human amylin in islet beta-cells","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2024.107252_bb0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0195","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2174\/1567205011666141107124538","article-title":"Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer\u2019s disease","volume":"11","author":"Fawver","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bpc.2024.107252_bb0200","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bpc.2024.107252_bb0205","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1177\/0271678X16657093","article-title":"Amylin alters human brain pericyte viability and NG2 expression","volume":"37","author":"Schultz","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bpc.2024.107252_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-160047","article-title":"Intraneuronal amylin deposition, peroxidative membrane injury and increased IL-1\u03b2 synthesis in brains of Alzheimer\u2019s disease patients with type-2 diabetes and diabetic HIP rats","volume":"53","author":"Verma","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bpc.2024.107252_bb0215","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ana.24992","article-title":"Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia","volume":"82","author":"Ly","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2018.05.003","article-title":"Levels of retinal IAPP are altered in Alzheimer\u2019s disease patients and correlate with vascular changes and hippocampal IAPP levels","volume":"69","author":"Schultz","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bpc.2024.107252_bb0225","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.25570","article-title":"Amylin as a potential link between type 2 diabetes and Alzheimer disease","volume":"86","author":"Martinez-Valbuena","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0230","article-title":"The association of circulating amylin with \u03b2-amyloid in familial Alzheimer\u2019s disease","volume":"7, e12130","author":"Ly","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bpc.2024.107252_bb0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s42003-022-04398-2","article-title":"A\u03b2 efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas","volume":"6","author":"Verma","year":"2023","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.bpc.2024.107252_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104682","article-title":"Rapid, scalable assay of amylin-\u03b2 amyloid co-aggregation in brain tissue and blood","volume":"299","author":"Kotiya","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2024.107252_bb0245","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2024.107252_bb0250","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bpc.2024.107252_bb0255","doi-asserted-by":"crossref","first-page":"fcz036","DOI":"10.1093\/braincomms\/fcz036","article-title":"& Alzheimer\u2019s disease neuroimaging initiative. Blood-based protein mediators of senility with replications across biofluids and cohorts","volume":"2","author":"Royall","year":"2019","journal-title":"Brain Commun."},{"key":"10.1016\/j.bpc.2024.107252_bb0260","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mp.2016.35","article-title":"& Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer\u2019s disease","volume":"22","author":"Roostaei","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bpc.2024.107252_bb0265","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00259-018-3995-2","article-title":"Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds","volume":"45","author":"Wagner","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bpc.2024.107252_bb0270","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00125-018-4695-y","article-title":"Use of the PET ligand florbetapir for in vivo imaging of pancreatic islet amyloid deposits in hIAPP transgenic mice","volume":"61","author":"Templin","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2024.107252_bb0275","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.2337\/db16-0044","article-title":"Hyperamylinemia increases IL-1\u03b2 synthesis in the heart via peroxidative sarcolemmal injury","volume":"65","author":"Liu","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2024.107252_bb0280","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","article-title":"Diabetes due to a progressive defect in \u03b2-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat): a new model for type 2 diabetes","volume":"53","author":"Butler","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2024.107252_bb0285","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCRESAHA.111.258285","article-title":"Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats","volume":"110","author":"Despa","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bpc.2024.107252_bb0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.kint.2019.07.028","article-title":"Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries","volume":"97","author":"Verma","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.bpc.2024.107252_bb0295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1326-9-30","article-title":"Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin","volume":"9","author":"Srodulski","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bpc.2024.107252_bb0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002305","article-title":"Amylin deposition in the kidney of patients with diabetic nephropathy","volume":"72","author":"Gong","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bpc.2024.107252_bb0305","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.bbadis.2017.10.024","article-title":"Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal Ca2+ leak is independent of diabetic remodeling of myocardium","volume":"1864","author":"Liu","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bpc.2024.107252_bb0310","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11306-016-1022-9","article-title":"Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo","volume":"12","author":"Ilaiwy","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.bpc.2024.107252_bb0315","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1002\/jcp.29659","article-title":"Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages","volume":"235","author":"Watanabe","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bpc.2024.107252_bb0320","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mp.2016.230","article-title":"Molecular interaction between type 2 diabetes and Alzheimer\u2019s disease through cross-seeding of protein misfolding","volume":"22","author":"Moreno-Gonzalez","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bpc.2024.107252_bb0325","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1096\/fj.201700431R","article-title":"Amyloid-\u03b2 and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model","volume":"31","author":"Wijesekara","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bpc.2024.107252_bb0330","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bpc.2024.107252_bb0335","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s13679-018-0300-4","article-title":"Future pharmacotherapy for obesity: new anti-obesity drugs on the horizon","volume":"7","author":"Srivastava","year":"2018","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.bpc.2024.107252_bb0340","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/ana.26072","article-title":"Amylin analog pramlintide induces migraine-like attacks in patients","volume":"89","author":"Ghanizada","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bpc.2024.107252_bb0345","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ejp.898","article-title":"Amylin modulates the formalin-induced tonic pain behaviours in rats","volume":"20","author":"Potes","year":"2016","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.bpc.2024.107252_bb0350","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.npep.2015.12.011","article-title":"Effects of intrathecal amylin on formalin-induced nociception and on cAMP accumulation in the rat embryonic spinal cells","volume":"57","author":"Khoshdel","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bpc.2024.107252_bb0355","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.metabol.2004.04.010","article-title":"Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects","volume":"53","author":"Heise","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.bpc.2024.107252_bb0360","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0169-328X(98)00269-1","article-title":"Reduced nociceptive behavior in islet amyloid polypeptide (amylin) knockout mice","volume":"63","author":"Gebre-Medhin","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.bpc.2024.107252_bb0365","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bpc.2024.107252_bb0370","doi-asserted-by":"crossref","first-page":"14588","DOI":"10.1038\/s41598-019-51088-x","article-title":"Altered metabolic gene expression in the brain of a triprolyl-human amylin transgenic mouse model of type 2 diabetes","volume":"9","author":"Nie","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462224000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462224000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:11:14Z","timestamp":1777547474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462224000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":74,"alternative-id":["S0301462224000814"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2024.107252","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroinflammation induced by amyloid-forming pancreatic amylin: Rationale for a mechanistic hypothesis","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2024.107252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107252"}}